Bored Panda Once used primarily for diabetes, Ozempic surged into the mainstream in 2023 as a celebrity backed weight loss fix. Many have since shared Instagram Is This the End for Compounded Tirzepatide? Judge Says NO to Injunction The FDA has approved semaglutide (Ozempic) to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD). New Trial Results Position Mounjaro for FDA Weight Loss Drug Approval DiaTribe